GBA1 and Parkinson disease: It has previously been demonstrated that GCase activity is reduced in pathologically affected brain tissue (Murphy et al., 2014) and monocytes (Atashrazm et al., 2018) from PD subjects not harboring GBA mutations, suggesting a role of GCase activity in cases beyond those with GBA mutations.